Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Among 451 incident cases of papillary thyroid cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results